Skip to main content
Clinical Trials/ACTRN12621001345875
ACTRN12621001345875
Not yet recruiting
未知

Clinical outcomes of an eHealth-facilitated model of type 2 diabetes care in regional, rural and remote populations: The REMODeL-R3 trial

niversity of Queensland0 sites112 target enrollmentOctober 7, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
niversity of Queensland
Enrollment
112
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 7, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Queensland

Eligibility Criteria

Inclusion Criteria

  • People living with type 2 diabetes, attending the PA diabetes telehealth service:
  • with a glycated haemoglobin (HbA1c) \>8%,
  • with an age \>\=18 years,
  • with pre\-existing type 2 diabetes for at least 6 months, and
  • on insulin.

Exclusion Criteria

  • The exclusion criteria will be participants
  • those referred to conventional IDA
  • those using the insulin pump, flash glucose monitoring or continuous glucose monitoring devices,
  • with a recent bariatric surgery of less than 12 months,
  • unable to communicate in English,
  • who are pregnant or those planning pregnancy in the next 12 months,
  • on insulin Ryzodeg
  • those who do not have a reliable internet connection (either through Wi\-fi at home or 3G/4G).

Outcomes

Primary Outcomes

Not specified

Similar Trials